{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:03:43Z","timestamp":1778677423150,"version":"3.51.4"},"reference-count":32,"publisher":"Impact Journals, LLC","issue":"45","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2020,11,10]]},"DOI":"10.18632\/oncotarget.27797","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T15:42:07Z","timestamp":1605022927000},"page":"4123-4137","source":"Crossref","is-referenced-by-count":8,"title":["Expression profiling on subclasses of primary parotid gland carcinomas"],"prefix":"10.18632","volume":"11","author":[{"given":"Jeannine","family":"Meinrath","sequence":"first","affiliation":[{"name":"Institute of Pathology, University Hospital of Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Haak","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Halle, Halle, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nesrin","family":"Igci","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital of Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Dalvi","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital of Cologne, Cologne, Germany"},{"name":"Center for Molecular Medicine, University of Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Arolt","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital of Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Meemboor","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital of Cologne, Cologne, Germany"},{"name":"Center of Integrative Oncology, University Hospital of Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Siebolts","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Halle, Halle, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Eischeidt-Scholz","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital of Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Wickenhauser","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Halle, Halle, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inga","family":"Gr\u00fcnewald","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital of M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uta","family":"Drebber","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital of Cologne, Cologne, Germany"},{"name":"Center of Integrative Oncology, University Hospital of Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"B\u00fcttner","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital of Cologne, Cologne, Germany"},{"name":"Center for Molecular Medicine, University of Cologne, Cologne, Germany"},{"name":"Center of Integrative Oncology, University Hospital of Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Quaas","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital of Cologne, Cologne, Germany"},{"name":"Center of Integrative Oncology, University Hospital of Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens-Peter","family":"Klu\u00dfmann","sequence":"additional","affiliation":[{"name":"Center of Integrative Oncology, University Hospital of Cologne, Cologne, Germany"},{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarete","family":"Odenthal","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital of Cologne, Cologne, Germany"},{"name":"Center for Molecular Medicine, University of Cologne, Cologne, Germany"},{"name":"Center of Integrative Oncology, University Hospital of Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Beutner","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Cologne, Germany"},{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Meyer","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Cologne, Germany"},{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Essen, University Duisburg-Essen, Duisburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.oraloncology.2011.09.005","article-title":"Salivary gland carcinoma in Denmark 1990-2005: Outcome and prognostic factors. Results of the Danish Head and Neck Cancer Group (DAHANCA)","volume":"4","author":"Godballe","year":"2012","journal-title":"Oral Oncol"},{"key":"2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.oraloncology.2011.04.020","article-title":"Salivary gland carcinoma in Denmark 1990-2005: A national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA)","volume":"4","author":"Godballe","year":"2011","journal-title":"Oral Oncol"},{"key":"3","unstructured":"El-Naggar, Chan, Grandis, Takata, Slootweg. WHO Classification of Head and Neck Tumors, Vol. 9, 4th ed. IARC Publications. 2017. https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/WHO-Classification-Of-Head-And-Neck-Tumours-2017."},{"key":"4","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.oraloncology.2013.06.009","article-title":"Comparison of TNM-based stage grouping versus UICC\/AJCC stage grouping (7th edition) in malignant parotid gland tumors","volume":"4","author":"Beutner","year":"2013","journal-title":"Oral Oncol"},{"key":"5","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ejso.2008.02.004","article-title":"Patterns of lymph node spread and its influence on outcome in resectable parotid cancer","volume":"3","author":"Guntinas-Lichius","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0360-3016(96)00464-6","article-title":"Postoperative radiotherapy for malignant tumors of the parotid gland","volume":"3","author":"Peters","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1200\/JCO.2005.05.3025","article-title":"Systemic therapy in the palliative management of advanced salivary gland cancers","volume":"2","author":"Licitra","year":"2006","journal-title":"J Clin Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.oraloncology.2014.04.008","article-title":"Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers","volume":"5","author":"Andersson","year":"2014","journal-title":"Oral Oncol"},{"key":"9","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.joms.2005.03.006","article-title":"Management and outcome of patients with malignant salivary gland tumors","volume":"6","author":"Potter","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/hed.21316","article-title":"Interpretation of treatment outcome in the clinically node-negative neck in primary parotid carcinoma: a systematic review of the literature","volume":"3","author":"Smeele","year":"2010","journal-title":"Head Neck"},{"key":"11","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1186\/s12885-015-2015-1","article-title":"Clinical significance of OCT4 and SOX2 protein expression in cervical cancer","volume":"1","author":"Hewitt","year":"2015","journal-title":"BMC Cancer"},{"key":"12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3816\/CCC.2011.n.009","article-title":"Effect of KRAS mutational status in advanced colorectal cancer on the outcomes of anti-epidermal growth factor receptor monoclonal antibody therapy: a systematic review and meta-analysis","volume":"1","author":"Salpeter","year":"2011","journal-title":"Clin Colorectal Cancer"},{"key":"13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial","volume":"1","author":"Garrido","year":"2012","journal-title":"Lancet Oncol"},{"key":"14","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.1158\/1078-0432.CCR-10-2571","article-title":"New strategies in overcoming acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer","volume":"1","author":"Pao","year":"2011","journal-title":"Clin Cancer Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"18224","DOI":"10.18632\/oncotarget.4015","article-title":"Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneity","volume":"6","author":"Stenner","year":"2015","journal-title":"Oncotarget"},{"key":"16","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.ejca.2011.06.052","article-title":"New drugs in melanoma: it\u2019s a whole new world","volume":"4","author":"Robert","year":"2011","journal-title":"Eur J Cancer"},{"key":"17","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","article-title":"Wnt signaling in cancer","volume":"3","author":"Boutros","year":"2017","journal-title":"Oncogene"},{"key":"18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/0092-8674(88)90220-6","article-title":"Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice","volume":"5","author":"Varmus","year":"1988","journal-title":"Cell"},{"key":"19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1001\/archotol.134.1.94","article-title":"Dysregulation of Wnt pathway components in human salivary gland tumors","volume":"13","author":"Reis","year":"2008","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ng0297-170","article-title":"Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations","volume":"1","author":"Van de Ven","year":"1997","journal-title":"Nat Genet"},{"key":"21","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/sj.onc.1201660","article-title":"The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in upregulation of PLAG1 gene expression under control of the LIFR promoter","volume":"1","author":"Van de Ven","year":"1998","journal-title":"Oncogene"},{"key":"22","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/ijc.23586","article-title":"Adenomyoepitheliomatous lesions of the mammary glands in transgenic mice with targeted PLAG1 overexpression","volume":"12","author":"Van de Ven","year":"2008","journal-title":"Int J Cancer"},{"key":"23","first-page":"1041","article-title":"Upregulation of Igf and Wnt Signalling Associated Genes in Pleomorphic. Adenomas of the Salivary Glands in PLAG1 Transgenic Mice","volume":"3","author":"Van de Ven","year":"2008","journal-title":"Int J Oncol"},{"key":"24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s11523-017-0507-4","article-title":"Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics","volume":"1","author":"Mita","year":"2017","journal-title":"Target Oncol"},{"key":"25","first-page":"S2145","article-title":"Aberrant Wnt-1\/beta-catenin signaling and WIF-1 deficiency are important events which promote tumor cell invasion and metastasis in salivary gland adenoid cystic carcinoma","volume":"2","author":"Chen","year":"2015","journal-title":"Biomed Mater Eng"},{"key":"26","doi-asserted-by":"publisher","first-page":"98298","DOI":"10.18632\/oncotarget.21176","article-title":"Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis","volume":"8","author":"Blom","year":"2017","journal-title":"Oncotarget"},{"key":"27","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.1038\/onc.2016.98","article-title":"Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer","volume":"3","author":"Jirstr\u00f6m","year":"2016","journal-title":"Oncogene"},{"key":"28","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00405-013-2488-y","article-title":"A perspective of comparative salivary and breast pathology. Part I: microstructural aspects, adaptations and cellular events","volume":"27","author":"Ferlito","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1146\/annurev-med-062913-051343","article-title":"The PI3K\/AKT Pathway as a Target for Cancer Treatment","volume":"6","author":"Arteaga","year":"2016","journal-title":"Annu Rev Med"},{"key":"30","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1158\/1535-7163.MCT-10-0994","article-title":"PIK3CA mutations in patients with advanced cancers treated with PI3K\/AKT\/mTOR axis inhibitors","volume":"1","author":"Kurzrock","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"31","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1158\/1078-0432.CCR-19-3758","article-title":"The immune microenvironment and neoantigen landscape of aggressive salivary gland carcinomas differ by subtype","volume":"2","author":"Morris","year":"2020","journal-title":"Clin Cancer Res"},{"key":"32","doi-asserted-by":"publisher","first-page":"11069","DOI":"10.1038\/s41598-017-11345-3","article-title":"Evolution analysis of heterogeneous non-small cell lung carcinoma by ultra-deep sequencing of the mitochondrial genome","volume":"7","author":"Odenthal","year":"2017","journal-title":"Sci Rep"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27797","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T15:43:14Z","timestamp":1605022994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":32,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2020,11,10]]}},"alternative-id":["27797"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.27797","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,10]]}}}